about
Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reamingFracture healing: mechanisms and interventionsTendon regeneration and scar formation: The concept of scarless healingBMP treatment of C3H10T1/2 mesenchymal stem cells induces both chondrogenesis and osteogenesis.Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing.Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing.Micro-computed tomography assessment of fracture healing: relationships among callus structure, composition, and mechanical function.Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing.Growth factor regulation of fracture repair.Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.Skeletal trauma generates systemic BMP2 activation that is temporally related to the mobilization of CD73+ cells.Role of Fas and Treg cells in fracture healing as characterized in the fas-deficient (lpr) mouse model of lupus.Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activityIntrinsic Sex-Linked Variations in Osteogenic and Adipogenic Differentiation Potential of Bone Marrow Multipotent Stromal CellsFracture healing as a post-natal developmental process: molecular, spatial, and temporal aspects of its regulation.Diabetes reduces mesenchymal stem cells in fracture healing through a TNFα-mediated mechanismAcute phosphate restriction leads to impaired fracture healing and resistance to BMP-2.Urine matrix metalloproteinases (MMPs) as biomarkers for the progression of fracture healingGeneration of closed transverse fractures in small animals.The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development.Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesisGene expression and extracellular matrix ultrastructure of a mineralizing chondrocyte cell culture systemTributyltin engages multiple nuclear receptor pathways and suppresses osteogenesis in bone marrow multipotent stromal cellsColloidal-gold immunocytochemical localization of osteopontin in avian eggshell gland and eggshell.Expression of type I and III collagen genes during differentiation of embryonic chicken myoblasts in culture.Vascular tissues are a primary source of BMP2 expression during bone formation induced by distraction osteogenesisBone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling.Autogenous regulation of a network of bone morphogenetic proteins (BMPs) mediates the osteogenic differentiation in murine marrow stromal cells.Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized.Diabetes causes the accelerated loss of cartilage during fracture repair which is reversed by insulin treatment.Role of hypoxia inducible factor-1 alpha pathway in bone regeneration.VEGF and bone cell signalling: an essential vessel for communication?Overview of skeletal repair (fracture healing and its assessment).The role of angiogenesis in a murine tibial model of distraction osteogenesis.The transcriptome of fracture healing defines mechanisms of coordination of skeletal and vascular development during endochondral bone formation.Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis.Expression and role of interleukin-6 in distraction osteogenesis.Sex-Linked Skeletal Phenotype of Lysyl Oxidase Like-1 Mutant Mice.Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.
P50
Q26827481-072A61F5-1900-4B79-9731-5475CAB49A73Q26851958-AAA1DABD-43C4-4D55-B63D-6B5497FD117EQ29042595-A944BE28-100E-4CCC-AF4B-04E40CFBAE0CQ31028194-38BD0B6D-9EF0-4B69-AE2C-860E3215E196Q33213072-2AA80250-486C-4FCF-BB4F-6FDF2AE513EFQ33365327-5088DF63-02C8-46BB-8463-03B3428E6D1CQ33384778-0D0F3D06-3289-4ECB-AB39-8B7032A0C9BDQ33385262-4B2C6821-DB01-4F1C-BEE5-6502C444C32BQ33778850-8DA9A6D7-8AAE-4195-892D-B041919643B7Q33819359-90FE947A-A11E-4FDB-9D82-559A87F510B1Q34677910-338FA8B7-0728-4671-B56A-C777CB9B99C4Q35008584-63AC7367-861A-4448-BF8A-936E81282ECEQ35029163-8C868E00-14AD-4F8D-9E9E-A948B11E443AQ35050135-73DB70F5-F9EE-4838-8B6C-2AAA30D698D8Q35077692-E94A94B0-9F1B-4F84-92B0-47AFE29A599DQ35137241-95C94D79-F81D-4580-B768-CE97A31464D8Q35156052-353F11D7-A7C2-4508-B465-148B9FA0BEC7Q35350100-5D2FB722-0292-4CF5-B097-06D996B1E480Q35730423-262AA73B-1460-4E70-B99A-BDFD6373D32CQ35813751-8F2222D2-34D9-4B1B-88E1-234C32F366B9Q35878806-BD71BBA4-01CD-41ED-81FF-024DC3553F95Q36375852-63B08975-DC9C-40A7-BB63-954D08F636DBQ36529161-458EC877-BCD8-4DD0-B0E0-17AB55C5802AQ36533766-2B915F44-854E-40C4-96C6-57A4A1CDD221Q36572912-F4A3631D-F9FC-41C2-A9D9-292D07DDC554Q36946316-5D72672C-0241-414E-8CCC-DD7A22CEBDDBQ37037233-EA3A16B4-2D6D-4609-9A4C-14A6C60B2A6EQ37172751-1EC54BB3-F700-4AC8-89F1-07272C30F42DQ37189442-8566DD12-F68C-41CB-8013-9CE49AE3F363Q37207072-FCC16DAE-6D60-4BC5-A92F-E664BC803816Q37238865-586972BC-53B1-4BD8-9C66-7638F1D0DAD4Q37369794-32C2F165-A38C-47E6-9605-78F4B7FEA84EQ38057998-0A98753F-D863-4770-A62B-8A18E56421A1Q38183792-3E4AF931-1F0B-4999-9C8E-B2B119FB6C7DQ38341820-EF52D4EA-B476-4A5E-8D71-11ABBDAA05ACQ38501191-287EC092-8443-41D8-BCC3-937EBFC0571DQ40099130-AD9182A8-A039-44D1-9CAC-0C728BB4EC0BQ40162893-739CE0BE-E03D-4C23-A29F-5BDFB5260C34Q40354992-99FC9D8D-B249-4F35-A6B3-F4DF43D6052AQ40539678-084C2E82-32FF-4900-B153-4DD9772172A0
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
Gerstenfeld LC
@ast
Gerstenfeld LC
@en
Gerstenfeld LC
@es
Gerstenfeld LC
@nl
type
label
Gerstenfeld LC
@ast
Gerstenfeld LC
@en
Gerstenfeld LC
@es
Gerstenfeld LC
@nl
prefLabel
Gerstenfeld LC
@ast
Gerstenfeld LC
@en
Gerstenfeld LC
@es
Gerstenfeld LC
@nl
P31
P496
0000-0002-0477-1211